Skip to content
Riskpilot
← Back to search
Sign in
Get full access
MirReMed AB
AB
Active
Org 5592813413
Edsviksvägen 83, 182 35
Danderyd
Medical specialists activities
· NACE 8622
Est. 2020
0 employees
Watchlist
Share
Sweden
/
Companies
/
Medical specialists activities
/
MirReMed AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
—
−8
−2
−3
1
Depreciation & amort.
−0
—
—
—
—
EBIT
0
−8
−2
−3
1
Net financials
—
—
—
—
0
Profit before tax
0
−8
−2
−3
1
Tax
−0
—
—
—
—
Net profit
0
−8
−2
−3
1
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
8 730
8 725
8 714
8 711
9 175
Equity
25
17
15
13
13
Long-term debt
8 697
8 697
8 697
8 697
9 157
Short-term debt
7
11
2
2
5
Total debt
8 704
8 708
8 699
8 699
9 162
Financial ratios
5-year trend
EBITDA margin
69500.0%
This company
15.8%
Market median
+439773% vs market
2021
2025
Equity ratio
0.1%
This company
38.2%
Market median
-100% vs market
2021
2025
Return on equity
5.3%
This company
18.4%
Market median
-71% vs market
2021
2025
Net profit margin
69900.0%
This company
8.1%
Market median
+862863% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
692.55×
This company
0.62×
Market median
-111602% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-12-31
View
PDF
More on MirReMed AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network